Loading...

Fatta Nahab

TitleAssociate Professor
InstitutionUniversity of California San Diego
DepartmentNeurosciences
Address4510 Executive Drive, Suite 325
San Diego CA 92121
Phone858-822-1399
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response.
    NIH/NINDS R01NS073683Jul 1, 2011 - Mar 31, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pahwa R, Isaacson SH, Torres-Russotto D, Nahab FB, Lynch PM, Kotschet KE. Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson's disease: recommendations from an expert panel. Expert Rev Neurother. 2018 Jul 26; 1-12. PMID: 30032695.
      View in: PubMed
    2. Luca CC, Nadayil G, Dong C, Nahab FB, Field-Fote E, Singer C. Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial. J Neurol Sci. 2017 Aug 15; 379:7-11. PMID: 28716283.
      View in: PubMed
    3. Nahab FB, Kundu P, Maurer C, Shen Q, Hallett M. Impaired sense of agency in functional movement disorders: An fMRI study. PLoS One. 2017; 12(4):e0172502. PMID: 28448504.
      View in: PubMed
    4. Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS. Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Mov Disord. 2016 Dec; 31(12):1874-1882. PMID: 27753188.
      View in: PubMed
    5. Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, Litvan I, Simuni T, Dorsey ER, Burack MA, Kubota K, Kamondi A, Godinho C, Daneault JF, Mitsi G, Krinke L, Hausdorff JM, Bloem BR, Papapetropoulos S. Technology in Parkinson's disease: Challenges and opportunities. Mov Disord. 2016 09; 31(9):1272-82. PMID: 27125836.
      View in: PubMed
    6. Dashtipour K, Chen JJ, Frei K, Nahab F, Tagliati M. Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm. Tremor Other Hyperkinet Mov (N Y). 2015; 5:338. PMID: 26566457; PMCID: PMC4636029.
    7. Kang SY, Im CH, Shim M, Nahab FB, Park J, Kim DW, Kakareka J, Miletta N, Hallett M. Correction: Brain Networks Responsible for Sense of Agency: An EEG Study. PLoS One. 2015; 10(9):e0137769. PMID: 26332447; PMCID: PMC4557977.
    8. Kang SY, Im CH, Shim M, Nahab FB, Park J, Kim DW, Kakareka J, Miletta N, Hallett M. Brain Networks Responsible for Sense of Agency: An EEG Study. PLoS One. 2015; 10(8):e0135261. PMID: 26270552; PMCID: PMC4536203.
    9. Pandey S, Nahab F, Aldred J, Nutt J, Hallett M. Post-traumatic shoulder movement disorders: A challenging differential diagnosis between organic and functional. Mov Disord Clin Pract. 2014 Jun 01; 1(2):102-105. PMID: 25197686.
      View in: PubMed
    10. Haubenberger D, Nahab FB, Voller B, Hallett M. Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time? Tremor Other Hyperkinet Mov (N Y). 2014; 4. PMID: 24587968; PMCID: PMC3918508.
    11. Nuytemans K, Bademci G, Kohli MM, Beecham GW, Wang L, Young JI, Nahab F, Martin ER, Gilbert JR, Benatar M, Haines JL, Scott WK, Züchner S, Pericak-Vance MA, Vance JM. C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease. Ann Hum Genet. 2013 Sep; 77(5):351-63. PMID: 23845100; PMCID: PMC3815478.
    12. Haubenberger D, McCrossin G, Lungu C, Considine E, Toro C, Nahab FB, Auh S, Buchwald P, Grimes GJ, Starling J, Potti G, Scheider L, Kalowitz D, Bowen D, Carnie A, Hallett M. Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology. 2013 Mar 05; 80(10):933-40. PMID: 23408867; PMCID: PMC3653213.
    13. Levin BE, Katzen HL, Maudsley A, Post J, Myerson C, Govind V, Nahab F, Scanlon B, Mittel A. Whole-brain proton MR spectroscopic imaging in Parkinson's disease. J Neuroimaging. 2014 Jan-Feb; 24(1):39-44. PMID: 23228009; PMCID: PMC4593470.
    14. Nahab FB, Handforth A, Brown T, Shin C, Quesada A, Dong C, Haubenberger D, Hallett M. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics. 2012 Jul; 9(3):635-8. PMID: 22454323.
      View in: PubMed
    15. Wallace DM, Shafazand S, Carvalho DZ, Nahab FB, Sengun C, Russell A, Moore HP, Singer C. Sleep-related falling out of bed in Parkinson's disease. J Clin Neurol. 2012 Mar; 8(1):51-7. PMID: 22523513; PMCID: PMC3325432.
    16. Nahab FB, Wittevrongel L, Ippolito D, Toro C, Grimes GJ, Starling J, Potti G, Haubenberger D, Bowen D, Buchwald P, Dong C, Kalowitz D, Hallett M. An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor. Neurotherapeutics. 2011 Oct; 8(4):753-62. PMID: 21594724; PMCID: PMC3250299.
    17. Haubenberger D, Kalowitz D, Nahab FB, Toro C, Ippolito D, Luckenbaugh DA, Wittevrongel L, Hallett M. Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Mov Disord. 2011 Sep; 26(11):2073-80. PMID: 21714004; PMCID: PMC4117681.
    18. Katzen H, Myerson C, Papapetropoulos S, Nahab F, Gallo B, Levin B. Multi-modal hallucinations and cognitive function in Parkinson's disease. Dement Geriatr Cogn Disord. 2010; 30(1):51-6. PMID: 20689283; PMCID: PMC2974841.
    19. Nahab FB, Kundu P, Gallea C, Kakareka J, Pursley R, Pohida T, Miletta N, Friedman J, Hallett M. The neural processes underlying self-agency. Cereb Cortex. 2011 Jan; 21(1):48-55. PMID: 20378581; PMCID: PMC3000563.
    20. Nahab FB. Exploring yawning with neuroimaging. Front Neurol Neurosci. 2010; 28:128-33. PMID: 20357471.
      View in: PubMed
    21. Nahab FB, Hallett M. Current role of functional MRI in the diagnosis of movement disorders. Neuroimaging Clin N Am. 2010 Feb; 20(1):103-10. PMID: 19959022.
      View in: PubMed
    22. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Züchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet. 2010 Mar; 74(2):97-109. PMID: 20070850; PMCID: PMC2853717.
    23. Nahab FB, Hattori N, Saad ZS, Hallett M. Contagious yawning and the frontal lobe: an fMRI study. Hum Brain Mapp. 2009 May; 30(5):1744-51. PMID: 18937281.
      View in: PubMed
    24. Nahab FB, Peckham EL, Hallett M. Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome. Neurology. 2008 Sep 16; 71(12):950-1. PMID: 18794499; PMCID: PMC2676942.
    25. Nahab FB, Peckham E, Hallett M. Essential tremor, deceptively simple.... Pract Neurol. 2007 Aug; 7(4):222-33. PMID: 17636137.
      View in: PubMed
    26. Nahab FB, Worrell GA, Weinshenker BG. 25-year-old man with recurring headache and confusion. Mayo Clin Proc. 2001 Jan; 76(1):75-8. PMID: 11155417.
      View in: PubMed
    27. Iacono RP, Nahab FB, Nahab FH. Serotonergic decompensation in the akinetic expression of Parkinson's disease. Int J Neurosci. 2000; 101(1-4):57-63. PMID: 10765990.
      View in: PubMed
    Fatta's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _